ERBITUX (ImClone LLC)
Welcome to the PulseAid listing for the ERBITUX drug offered from ImClone LLC. This Epidermal Growth Factor Receptor Antagonist [EPC],HER1 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | ImClone LLC |
| NON-PROPRIETARY NAME: | cetuximab |
| SUBSTANCE NAME: | CETUXIMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Epidermal Growth Factor Receptor Antagonist [EPC],HER1 Antagonists [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2004-02-12 |
| END MARKETING DATE: | 0000-00-00 |
ERBITUX HUMAN PRESCRIPTION DRUG Details:
| Item Description | ERBITUX from ImClone LLC |
| LABELER NAME: | ImClone LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2004-02-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66733-948_05a5824d-cc23-451d-b89a-bea80070bd29 |
| PRODUCT NDC: | 66733-948 |
| APPLICATION NUMBER: | BLA125084 |
Other CETUXIMAB Pharmaceutical Manufacturers / Labelers:
